These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8703666)

  • 1. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans.
    Cargill RI; Lipworth BJ
    Br J Clin Pharmacol; 1995 Dec; 40(6):585-90. PubMed ID: 8703666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans.
    Cargill RI; Lipworth BJ
    Thorax; 1995 Feb; 50(2):183-5. PubMed ID: 7701460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed.
    Cargill RI; Lipworth BJ
    Pulm Pharmacol; 1994 Oct; 7(5):305-10. PubMed ID: 7626917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.
    Höhne C; Drzimalla M; Krebs MO; Boemke W; Kaczmarczyk G
    J Physiol Pharmacol; 2003 Dec; 54(4):497-510. PubMed ID: 14726606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade.
    Kiely DG; Cargill RI; Lipworth BJ
    Cardiovasc Res; 1995 Dec; 30(6):875-80. PubMed ID: 8746201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung.
    Zhao L; Hughes JM; Winter RJ
    Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1198-201. PubMed ID: 1443870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects.
    Cargill RI; Lipworth BJ
    Chest; 1996 Nov; 110(5):1220-5. PubMed ID: 8915224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.
    Cargill RI; Lipworth BJ
    Br J Clin Pharmacol; 1995 Jul; 40(1):11-8. PubMed ID: 8527262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide inhibits hypoxic pulmonary hypertension in rats.
    Klinger JR; Warburton RR; Pietras L; Hill NS
    J Appl Physiol (1985); 1998 May; 84(5):1646-52. PubMed ID: 9572812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute neurohormonal responses to hypoxaemia in man.
    Cargill RI; McFarlane LC; Coutie WJ; Lipworth BJ
    Eur J Appl Physiol Occup Physiol; 1996; 72(3):256-60. PubMed ID: 8820895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension.
    Hill NS; Klinger JR; Warburton RR; Pietras L; Wrenn DS
    Am J Physiol; 1994 Mar; 266(3 Pt 1):L308-15. PubMed ID: 8166300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor?
    Brunner-La Rocca HP; Woods RL; Kaye DM; Hastings J; Thomas CJ; Lambert E; Esler MD
    J Hypertens; 2002 Jun; 20(6):1195-201. PubMed ID: 12023691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers.
    Kiely DG; Cargill RI; Lipworth BJ
    Br J Clin Pharmacol; 1995 Oct; 40(4):313-8. PubMed ID: 8554932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men.
    Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of frusemide and hypoxia on the pulmonary vascular bed in man.
    Kiely DG; Cargill RI; Lipworth BJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):309-13. PubMed ID: 9088586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
    Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K
    Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
    Clin Sci (Lond); 1997 Feb; 92(2):159-65. PubMed ID: 9059317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI; Struthers AD; Lipworth BJ
    Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men.
    Florkowski CM; Richards AM; Espiner EA; Yandle TG; Frampton C
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1244-50. PubMed ID: 8184968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of natriuretic peptides in healthy men.
    Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.